<DOC>
	<DOCNO>NCT00150865</DOCNO>
	<brief_summary>Compare lumbar plexus block ropivacaine 0.475 % , 0.4 ml/kg saline . Each group randomize , include 30 patient . block perform preoperatively Surgery general anesthesia . Postoperative evaluation pain ( VAS ) first endpoint , also morphine consumption via PCA device . Follow-up : 24h . Expectation : sizeable reduction pain block , duration .</brief_summary>
	<brief_title>Evaluation Efficacy Lumbar Plexus Bloc After Hip Surgery</brief_title>
	<detailed_description>Compare lumbar plexus block ( randomize ) - ropivacaine 0.475 % , 0.4 ml/kg - saline 0.4 ml/kg . Each group include 30 patient . Block perform preoperatively . Surgery general anesthesia ( sufentanil , propofol , atracurium ; maintenance : sevoflurane nitrous oxide O2 . Sufentanil add peroperatively clinically need . Postoperative evaluation pain ( VAS , independant blind observer ) first endpoint , also morphine consumption via PCA device . Adverse effect ( nausea , vomit , etc ) record Follow-up : 24h . Expectation : sizeable reduction pain block , duration .</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>adult ASA 13 cognitive impairement ASA IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>ropivacaine</keyword>
	<keyword>posterior lumbar plexus block</keyword>
	<keyword>hip arthroplasy</keyword>
	<keyword>analgesia</keyword>
	<keyword>postoperative</keyword>
</DOC>